Bristol-Myers stock: why AstraZeneca merger is unlikely to happen
Covered by 2 sources · 2 articles
2 outlets - including Yahoo and Invezz - are covering this story. Bristol-Myers Squibb (BMY) stock is declining this morning, reversing its premarket gains as Wall Street digests bombshell reports of a potential transatlantic merger with AstraZeneca (AZN). According to media reports, the UK healthcare hea…
All coverage
AstraZeneca and Bristol Myers Squibb merger talks denied
Bristol-Myers stock: why AstraZeneca merger is unlikely to happen
Bristol-Myers Squibb (BMY) stock is declining this morning, reversing its premarket gains as Wall Street digests bombshell reports of a potential transatlantic merger with AstraZeneca (AZN). According to media reports, the UK healthcare hea…